Jam

MSP Recovery, Inc. (NASDAQ: MSPR) announced a non-binding term sheet for a secured term loan facility of up to $55 million to bolster working capital and growth. The facility is divided into two tranches and secured by a first-priority lien. Warrants issued to the lender, could represent roughly 46.0% of MSP Recovery’s fully diluted equity if fully drawn. The deal includes potential for the investor to acquire additional claim rights, and lender oversight, including a possible Chief Restructuring Officer appointment. Certain aspects are subject to shareholder approval.

Tulla Resources Group will acquire the remaining shares of THEMAC Resources Group for $0.08 per share, an 11% premium. Tulla, already holding 60.39% of THEMAC, needs shareholder (2/3 majority) and minority shareholder approval at an October 7, 2025 meeting. Key shareholders (18.64%) support the deal, expected to close mid-to-late October 2025. The board, backed by a fairness opinion, unanimously approved the arrangement. Upon completion, THEMAC will be delisted.

Exelixis, Inc. announced the promotion of Dana T. Aftab, Ph.D., to Executive Vice President, Research and Development. Aftab, with 25 years at Exelixis, will lead drug discovery, translational research, product development, and medical affairs. She played a critical role in developing CABOMETYX® (cabozantinib). The company aims to maximize its portfolio, including zanzalintinib. Amy Peterson, M.D., previously Executive Vice President, Product Development & Medical Affairs, has left Exelixis. Exelixis is focused on creating next-generation oncology medicines.

VCI Global (VCIG) launched its CyberSecure Cloud service in Malaysia, a military-grade encrypted data protection platform. The EAL4-certified service uses proprietary QuantVault technology and offers scalable storage (3TB-50TB) with automated backup and firewall. It targets Malaysia’s growing cybersecurity market, projected to reach US$700M by 2030. Expansion is planned for Singapore, Hong Kong, Dubai, and Indonesia, with a customer portal launching by September 2025. This aims to capture a significant share of the expanding ASEAN cybersecurity market, estimated to reach US$12.2B by 2030.

Tel Instrument (TIC) delayed its 10-K filing due to credit line negotiations, moving to the OTC Pink market temporarily. Simultaneously, TIC is raising capital with insider participation to strengthen its balance sheet and fund growth. Positively, the U.S. Navy approved full-rate production of TIC’s CRAFT upgrade KITS, with an initial order of 150 units, expected to increase annual revenue by $5 million. Increased adoption of SDR-OMNI test sets further diversifies revenue. TIC anticipates substantial revenue growth and profitability from the Navy contract and CRAFT production.

Fosun International highlighted its H1 2025 results in Shanghai, emphasizing strategic focus, innovation, and globalization. Chairman Guo Guangchang cited progress in biopharmaceuticals and a commitment to core sector dominance. Co-Chairman Wang Qunbin stressed prudent financial management and debt reduction, while Co-CEO Chen Qiyu emphasized an “Innovation + Globalization” strategy. Overseas revenue constitutes 53% of total revenue. CFO Gong Ping outlined goals to reduce debt to RMB 60 billion, achieve RMB 10 billion in profit, and increase dividend payout. Revenue reached RMB 87.28 billion.

Franklin Templeton is launching the Franklin Dividend Growth ETF (FRIZ), targeting long-term capital appreciation through investments in fundamentally sound, U.S.-based companies with dividend growth potential. Managed by the Franklin Equity Group, FRIZ will feature a concentrated portfolio emphasizing companies with resilient business models and sustainable advantages. The ETF expands Franklin Templeton’s active ETF offerings, providing clients with diversified dividend expertise via a tax-efficient structure. As of August 21, 2025, Franklin Templeton manages over $47 billion in ETF assets globally.

The COLLIGO-HCM study, part of the WAYFARER-HCM program, presented at ESC Congress 2025, demonstrates Camzyos’ efficacy and safety in treating obstructive hypertrophic cardiomyopathy (oHCM). Real-world data showed significant reduction in left ventricular outflow tract (LVOT) obstruction and symptom alleviation in a diverse patient population, aligning with previous clinical trials. Nearly 60% of patients improved NYHA class by week 24 and the benefits were sustained through 96 weeks. The study also suggests Camzyos allows for reduced use of other medications.

CleanTech Vanadium Mining (CTVFF) is expanding in the Illinois-Kentucky Fluorspar District (IKFD) with a binding option to purchase 970 acres for US$184,000. The properties abut historic mines and place CleanTech strategically within the prolific IKFD. This acquisition brings CleanTech’s total land holdings to over 8,150 acres in a region that once accounted for over 90% of US Fluorspar production. This move occurs amidst rising fluorspar prices.

Noah Holdings (NYSE: NOAH & HKEX: 6686) reported Q2 2025 net revenues of RMB 630 million, a 2.2% YoY increase, with non-GAAP net income surging 78.2% YoY. Overseas revenue accounted for nearly half of total net revenues. AUM reached RMB 145.1 billion. Noah is expanding its global presence, including a partnership with Coinbase for a stablecoin yield fund, and focusing on AI integration and operational efficiency to sustain growth. The company is strategically targeting global Chinese HNWIs with diverse product offerings and enhanced services.